Jenburkt Pharmaceuticals Limited

Jenburkt Pharmaceuticals Limited company information, Employees & Contact Information

Updated May 2026

Quick answer

Jenburkt Pharmaceuticals Limited is a Pharmaceutical Manufacturing company and founded in 1984. It has approximately 287 employees on record. Contact data was last refreshed in May 2026. Find Jenburkt Pharmaceuticals Limited's verified employee emails, phone numbers, headquarters address, and key decision makers below.

Our purpose at Jenburkt Pharmaceuticals Ltd is to serve those in need of quality healthcare by bringing revolutionary, life-changing therapeutic solutions that are accessible to all. We believe in serving our patients – through them, we serve God, humanity and nation. Way back in the twentieth century, a visionary in the field of healthcare and philanthropic work – Shri Nandlal Mulji Bhuta laid the foundation for several companies. Today, with over 850+ committed team members across functions pan-India,we have 11 million+ prescriptions generated annually from 400,000+ pharmacies across the globe. Our organisation caters to large government, semi-government institutions, missionary hospitals, public sector enterprises, etc. We enjoy an international presence, with our products exported to 13 countries globally including niche segments. In an ever-changing health landscape, our rapt attention to market trends, innovation, our keen focus on quality above all else, and our team’s restless perseverance to deliver ground-breaking new healthcare solutions set us apart.

Company Details

Employees
287
Founded
1984
Address
Nirmala Apartments, 93,j. P. Road,andheri West,india
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
HQ
Mumbai, Maharashtra
Looking for a particular Jenburkt Pharmaceuticals Limited employee's phone or email?

Jenburkt Pharmaceuticals Limited Questions

News

Can Jenburkt Pharmaceuticals Limited Deliver Consistent Free Cash Flows - Insider Selling & Step-by-Step Swing Trade Plans - Trung tâm Dự báo KTTV quốc gia

Can Jenburkt Pharmaceuticals Limited Deliver Consistent Free Cash Flows - Insider Selling & Step-by-Step Swing Trade Plans Trung tâm Dự báo KTTV quốc gia

Jenburkt Pharmaceuticals Forms Death Cross, Signaling Bearish Trend Ahead - Markets Mojo

Jenburkt Pharmaceuticals Forms Death Cross, Signaling Bearish Trend Ahead Markets Mojo

Bridging Medical Knowledge: Jenburkt Pharmaceuticals Ltd and NIMHANS Launch First-Ever Neuropathy Masterclass Series - Tribune India

Bridging Medical Knowledge: Jenburkt Pharmaceuticals Ltd and NIMHANS Launch First-Ever Neuropathy Masterclass Series Tribune India

Jenburkt Pharma Standalone June 2025 Net Sales at Rs 35.53 crore, up 9.19% Y-o-Y - Moneycontrol

Jenburkt Pharma Standalone June 2025 Net Sales at Rs 35.53 crore, up 9.19% Y-o-Y Moneycontrol

Jenburkt Pharmaceuticals Reports Flat Financial Performance Amid Rising Non-Operating Income in May 2025 - Markets Mojo

Jenburkt Pharmaceuticals Reports Flat Financial Performance Amid Rising Non-Operating Income in May 2025 Markets Mojo

Jenburkt Wellness launches D2C brand Zixa Strong - An innovative, fast-acting pain relief range - Times of India

Jenburkt Wellness launches D2C brand Zixa Strong - An innovative, fast-acting pain relief range Times of India

Jenburkt Pharma launches Covid-19 drug Favipiravir at Rs 39 per tablet - Business Standard

Jenburkt Pharma launches Covid-19 drug Favipiravir at Rs 39 per tablet Business Standard

We had to make Favivent cost-effective for everyone - theweek.in

We had to make Favivent cost-effective for everyone theweek.in

Jenburkt Pharmaceuticals Reports Mixed Financial Results for December Quarter 2024 - Markets Mojo

Jenburkt Pharmaceuticals Reports Mixed Financial Results for December Quarter 2024 Markets Mojo

Jenburkt Pharma launches FDC- Nervijen D3 - Medical Dialogues

Jenburkt Pharma launches FDC- Nervijen D3 Medical Dialogues

Jenburkt Pharma: Steady as a Rock - Moneylife

Jenburkt Pharma: Steady as a Rock Moneylife

Jenburkt Pharma to consider share buyback - Express Pharma

Jenburkt Pharma to consider share buyback Express Pharma

Jenburkt Pharmaceuticals Ltd. Reaches All-Time High Stock Price Amidst Positive Performance - Markets Mojo

Jenburkt Pharmaceuticals Ltd. Reaches All-Time High Stock Price Amidst Positive Performance Markets Mojo

Jenburkt Pharmaceuticals second in India to launch Favipiravir (FaviventTM) to fight COVID-19 - Express Pharma

Jenburkt Pharmaceuticals second in India to launch Favipiravir (FaviventTM) to fight COVID-19 Express Pharma

Jenburkt Pharmaceuticals Reaches All-Time High, Outperforms Sector and Sensex - Markets Mojo

Jenburkt Pharmaceuticals Reaches All-Time High, Outperforms Sector and Sensex Markets Mojo

Jenburkt Pharmaceuticals Ltd. Reaches All-Time High, Outperforms Sector and Sensex - Markets Mojo

Jenburkt Pharmaceuticals Ltd. Reaches All-Time High, Outperforms Sector and Sensex Markets Mojo

Jenburkt Pharma Share Price Target 2025, 2026, 2030, 2040, 2050 - shareprice-target.com

Jenburkt Pharma Share Price Target 2025, 2026, 2030, 2040, 2050 shareprice-target.com

Top Jenburkt Pharmaceuticals Limited Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant